Skip to main content
Livermore
Livermore
ZHEN

First Turn Management, LLC

SEC CIK
0001993440
Latest filing
Aug 14, 2026

Holdings in Q1 2026

Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.

Institution overview
Positions
33
0 vs. Q4 2025
Portfolio value
$895.1M
+$19.9M (+2.3%) vs. Q4 2025
Filed
May 15, 2026
SEC
Holdings of First Turn Management, LLC in Q1 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
MLTXMoonLake ImmunotherapeuticsCLASS A ORD315,563$5.88M0.7%+52,920+20.1%AddedHistory
QUREuniQure N.V.SHS615,489$10.1M1.1%+293,834+91.4%AddedHistory
OLMAOlema Pharmaceuticals, Inc.COM768,662$11.5M1.3%+150,948+24.4%AddedHistory
PRAXPraxis Precision Medicines, Inc.COM NEW42,441$13.7M1.5%+6,692+18.7%AddedHistory
ERASErasca, Inc.COM867,639$14.0M1.6%+867,639NewHistory
NTRANatera, Inc.COM81,077$16.2M1.8%+202+0.2%AddedHistory
VERAVera Therapeutics, Inc.CL A422,023$17.0M1.9%−179,751−29.9%ReducedHistory
TERNTerns Pharmaceuticals, Inc.COM326,694$17.2M1.9%−545,355−62.5%ReducedHistory
FULCFulcrum Therapeutics, Inc.COM2,256,109$17.3M1.9%+363,426+19.2%AddedHistory
ASNDAscendis Pharma A/SSPONSORED ADR76,300$17.5M1.9%−55,508−42.1%ReducedHistory
VRDNViridian Therapeutics, Inc.COM911,337$17.8M2.0%+220,809+32.0%AddedHistory
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES558,336$17.9M2.0%−335,137−37.5%ReducedHistory
PVLAPalvella Therapeutics, Inc.COM148,093$18.5M2.1%+148,093NewHistory
DNTHDianthus Therapeutics, Inc.COM220,921$18.5M2.1%+220,921NewHistory
CYTKCytokinetics IncCOM NEW283,700$18.7M2.1%−41,968−12.9%ReducedHistory
KYMRKymera Therapeutics, Inc.COM254,672$21.2M2.4%+48,227+23.4%AddedHistory
SRRKScholar Rock Holding CorpCOM446,390$21.9M2.5%−13,337−2.9%ReducedHistory
CELCCelcuity Inc.COM210,578$24.0M2.7%+210,578NewHistory
ELVNEnliven Therapeutics, Inc.COM623,839$24.5M2.7%+623,839NewHistory
ORICOric Pharmaceuticals, Inc.COM2,017,284$25.6M2.9%+6,977+0.3%AddedHistory
IDYAIDEAYA Biosciences, Inc.COM873,838$29.1M3.3%+150,185+20.8%AddedHistory
AXSMAxsome Therapeutics, Inc.COM188,772$31.9M3.6%−18,149−8.8%ReducedHistory
ROIVRoivant Sciences Ltd.SHS1,190,118$33.0M3.7%+3,301+0.3%AddedHistory
COGTCogent Biosciences, Inc.COM947,339$36.5M4.1%+123,056+14.9%AddedHistory
MIRMMirum Pharmaceuticals, Inc.COM400,464$37.0M4.1%−81,100−16.8%ReducedHistory
NUVLNuvalent, Inc.COM370,344$37.9M4.2%+1,647+0.4%AddedHistory
INSMINSMED IncCOM PAR $.01248,475$40.6M4.5%−15,818−6.0%ReducedHistory
APGEApogee Therapeutics, Inc.COM513,770$43.2M4.8%+38,931+8.2%AddedHistory
RVMDRevolution Medicines, Inc.COM468,376$45.5M5.1%−170,009−26.6%ReducedHistory
XENEXenon Pharmaceuticals Inc.COM786,844$45.8M5.1%−12,899−1.6%ReducedHistory
BBIOBridgeBio Pharma, Inc.COM695,718$51.7M5.8%+100,245+16.8%AddedHistory
ABVXAbivax S.A.SPONSORED ADS465,869$51.9M5.8%+84,636+22.2%AddedHistory
UTHRUnited Therapeutics CorpCOM104,726$62.1M6.9%+41,146+64.7%AddedHistory

Sold out since Q4 2025 (5)

Positions held at the end of Q4 2025 that are gone from this filing.

Positions of First Turn Management, LLC sold out since Q4 2025
SecurityClassShares in Q4 2025Value in Q4 2025% of portfolio in Q4 2025History
GHGuardant Health, Inc.COM271,685$27.7M3.2%History
ARGXArgenx SESPONSORED ADR23,256$19.6M2.2%History
RYTMRhythm Pharmaceuticals, Inc.COM146,303$15.7M1.8%History
RCUSArcus Biosciences, Inc.COM565,142$13.5M1.5%History
IRONDisc Medicine, Inc.COM153,206$12.2M1.4%History